Clinical Trials Browser

Phase 3 × Lymphoma, T-Cell, Cutaneous × Lenalidomide × Clear all

NCT01098656 2018-07-09

Lenalidomide Maintenance Post-debulking in Advanced CTCL

Phase 3 Terminated

DermatologicLymphoid

Lymphoma, Mycosis Fungoides, Sezary Syndrome, Lymphoma, T-Cell, Cutaneous